Aptevo Therapeutics Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

APVO

organization

SIC: 2834

Also known as: Aptevo Therapeutics Inc.

SEC Insider

$43.1M

499 transactions

Summary

Aptevo Therapeutics Inc. (APVO) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $25.7MSales: $17.2M20 insiders

Date	Insider	Type	Value
2025-11-10	Grant Grady III	Buy	$20K
2025-08-06	Harsanyi Zsolt	A	$0
2025-08-06	Kwon SoYoung(SVP, GC, BD & Corp Affairs)	A	$0
2025-08-06	Kunz Barbara Lopez	A	$0
2025-08-06	White Marvin L(President and CEO)	A	$0
2025-08-06	Lamothe Jeffrey G.(EVP, COO)	A	$0
2025-08-06	Niederhuber John	A	$0
2025-08-06	Huebner Dirk(SVP, CMO)	A	$0
2025-08-06	Grant Grady III	A	$0
2025-08-06	Taylor Daphne(SVP, CFO)	A	$0
2025-08-06	Abdun-Nabi Daniel	A	$0
2025-07-17	Lamothe Jeffrey G.(EVP, COO)	M	$0
2025-07-17	Lamothe Jeffrey G.(EVP, COO)	M	—
2025-07-17	White Marvin L(President and CEO)	M	$0
2025-07-17	White Marvin L(President and CEO)	M	—
2025-07-17	Kwon SoYoung(SVP, GC, BD & Corp Affairs)	M	$0
2025-07-17	Kwon SoYoung(SVP, GC, BD & Corp Affairs)	M	—
2025-07-17	Taylor Daphne(SVP, CFO)	M	$0
2025-07-17	Taylor Daphne(SVP, CFO)	M	—
2025-07-17	Niederhuber John	M	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Aptevo Therapeutics Inc. — Contributions, Lobbying & Contracts | Poliscope